| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.56 | 0.002 | 0.56 | Chemokine receptor agonist | 0.278 0.003 DBMET01768 | ||
| 0.509 | 0.002 | 0.509 | CXC chemokine receptor agonist | 0.214 0.003 DBMET01768 | ||
| 0.443 | 0.012 | 0.443 | Anesthetic general | 0.417 0.014 DBMET01768 | ||
| 0.433 | 0.004 | 0.433 | Check point kinase 2 inhibitor | 0.34 0.005 DBMET01768 | ||
| 0.423 | 0.005 | 0.423 | Cyclin-dependent kinase 1 inhibitor | 0.308 0.011 DBMET01768 | ||
| 0.395 | 0.003 | 0.395 | Transforming growth factor antagonist | 0.222 0.004 DBMET01768 | ||
| 0.406 | 0.022 | 0.406 | Calcium channel activator | 0.402 0.024 DBMET01768 | ||
| 0.389 | 0.005 | 0.389 | MAP kinase 9 inhibitor | 0.188 0.025 DBMET01768 | ||
| 0.422 | 0.047 | 0.429 | Angiogenesis inhibitor | 0.429 0.045 DBMET01768 | DBMET01768 | |
| 0.337 | 0.004 | 0.337 | Histone deacetylase stimulant | 0.308 0.004 DBMET01768 | ||
| 0.337 | 0.004 | 0.337 | Histone deacetylase SIRT1 stimulant | 0.308 0.004 DBMET01768 | ||
| 0.33 | 0.014 | 0.33 | Protein kinase (CK1) inhibitor | 0.183 0.047 DBMET01768 | ||
| 0.322 | 0.008 | 0.325 | I kappa B kinase epsilon inhibitor | 0.325 0.008 DBMET01768 | DBMET01768 | |
| 0.311 | 0.014 | 0.311 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.305 0.015 DBMET01768 | ||
| 0.399 | 0.107 | 0.399 | MAP kinase 1 inhibitor | 0.38 0.119 DBMET01768 | ||
| 0.32 | 0.029 | 0.32 | MAP kinase kinase 2 inhibitor | 0.313 0.031 DBMET01768 | ||
| 0.301 | 0.015 | 0.301 | Growth factor agonist | 0.279 0.02 DBMET01768 | ||
| 0.302 | 0.035 | 0.302 | Platelet aggregation inhibitor | 0.3 0.036 DBMET01768 | ||
| 0.289 | 0.028 | 0.289 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.225 0.043 DBMET01768 | ||
| 0.27 | 0.014 | 0.27 | Platelet activating factor antagonist | 0.224 0.021 DBMET01768 | ||
| 0.258 | 0.002 | 0.258 | Methionyl aminopeptidase 1 inhibitor | 0.203 0.003 DBMET01768 | ||
| 0.29 | 0.046 | 0.316 | Antimitotic | 0.316 0.04 DBMET01768 | DBMET01768 | |
| 0.244 | 0.01 | 0.244 | MAP kinase 8 inhibitor | 0.13 0.038 DBMET01768 | ||
| 0.364 | 0.136 | 0.364 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.25 | 0.028 | 0.25 | 3C-like protease (Human coronavirus) inhibitor | 0.168 0.077 DBMET01768 | ||
| 0.264 | 0.043 | 0.264 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.187 0.072 DBMET01768 | ||
| 0.268 | 0.049 | 0.268 | MAP-kinase-activated kinase 5 inhibitor | 0.261 0.053 DBMET01768 | ||
| 0.235 | 0.019 | 0.235 | Protein kinase (CK1) delta inhibitor | 0.146 0.055 DBMET01768 | ||
| 0.232 | 0.02 | 0.232 | Vascular endothelial growth factor 1 antagonist | 0.151 0.04 DBMET01768 | ||
| 0.271 | 0.059 | 0.34 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.34 0.038 DBMET01768 | DBMET01768 | |
| 0.23 | 0.021 | 0.23 | Cyclin-dependent kinase 3 inhibitor | 0.211 0.028 DBMET01768 | ||
| 0.234 | 0.026 | 0.234 | Phosphodiesterase inhibitor | 0.152 0.057 DBMET01768 | ||
| 0.257 | 0.052 | 0.257 | Clk dual-specificity kinase inhibitor | 0.196 0.082 DBMET01768 | ||
| 0.208 | 0.004 | 0.208 | Glutamate (mGluR1) antagonist | 0.124 0.01 DBMET01768 | ||
| 0.212 | 0.009 | 0.212 | Stem cell growth factor agonist | 0.139 0.023 DBMET01768 | ||
| 0.267 | 0.064 | 0.326 | Dyrk kinase inhibitor | 0.326 0.044 DBMET01768 | DBMET01768 | |
| 0.213 | 0.013 | 0.213 | Insulin receptor antagonist | 0.171 0.022 DBMET01768 | ||
| 0.25 | 0.051 | 0.25 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.207 0.072 DBMET01768 | ||
| 0.202 | 0.004 | 0.202 | Transforming growth factor beta 1 antagonist | 0.121 0.007 DBMET01768 | ||
| 0.254 | 0.056 | 0.254 | Anticonvulsant | |||
| 0.199 | 0.006 | 0.199 | MAP kinase kinase 8 inhibitor | 0.123 0.014 DBMET01768 | ||
| 0.244 | 0.053 | 0.27 | RNA-directed DNA polymerase inhibitor | 0.27 0.04 DBMET01768 | DBMET01768 | |
| 0.225 | 0.035 | 0.225 | Protein kinase (CK1) gamma 1 inhibitor | 0.148 0.07 DBMET01768 | ||
| 0.261 | 0.074 | 0.261 | Aryl hydrocarbon receptor agonist | 0.25 0.079 DBMET01768 | ||
| 0.214 | 0.028 | 0.214 | Aurora-B kinase inhibitor | 0.164 0.041 DBMET01768 | ||
| 0.234 | 0.05 | 0.234 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.184 0.071 DBMET01768 | ||
| 0.222 | 0.041 | 0.222 | Growth factor antagonist | 0.188 0.05 DBMET01768 | ||
| 0.185 | 0.009 | 0.185 | Glutamate (mGluR group I) antagonist | 0.084 0.035 DBMET01768 | ||
| 0.295 | 0.119 | 0.356 | GABA C receptor rho-3 antagonist | 0.356 0.082 DBMET01768 | DBMET01768 | |
| 0.208 | 0.032 | 0.208 | Insulin secretagoues | 0.197 0.037 DBMET01768 | ||
| 0.207 | 0.03 | 0.207 | Protein kinase (CK1) gamma 2 inhibitor | 0.119 0.066 DBMET01768 | ||
| 0.253 | 0.078 | 0.295 | DNA damaging | 0.295 0.059 DBMET01768 | DBMET01768 | |
| 0.187 | 0.015 | 0.187 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.157 0.018 DBMET01768 | ||
| 0.303 | 0.133 | 0.351 | Antibacterial | 0.351 0.101 DBMET01768 | DBMET01768 | |
| 0.21 | 0.041 | 0.21 | Protein kinase (CK1) gamma inhibitor | 0.125 0.085 DBMET01768 | ||
| 0.194 | 0.027 | 0.194 | Aurora-A kinase inhibitor | 0.121 0.054 DBMET01768 | ||
| 0.209 | 0.042 | 0.209 | Protein kinase (CK1) gamma 3 inhibitor | 0.164 0.075 DBMET01768 | ||
| 0.188 | 0.021 | 0.188 | Protein kinase (CK2) inhibitor | 0.179 0.023 DBMET01768 | ||
| 0.189 | 0.027 | 0.189 | Cyclin-dependent kinase 2 inhibitor | 0.118 0.054 DBMET01768 | ||
| 0.18 | 0.018 | 0.18 | Activin receptor-like kinase 4 inhibitor | 0.12 0.052 DBMET01768 | ||
| 0.173 | 0.012 | 0.173 | MAP kinase 10 inhibitor | 0.084 0.046 DBMET01768 | ||
| 0.187 | 0.027 | 0.187 | MAP kinase 12 inhibitor | 0.13 0.058 DBMET01768 | ||
| 0.186 | 0.028 | 0.186 | Protein kinase (CK2) alpha inhibitor | 0.18 0.029 DBMET01768 | ||
| 0.188 | 0.03 | 0.188 | Glutamate receptor antagonist | 0.168 0.04 DBMET01768 | ||
| 0.216 | 0.058 | 0.216 | Focal adhesion kinase 2 inhibitor | 0.169 0.102 DBMET01768 | ||
| 0.169 | 0.014 | 0.169 | Glutamate (mGluR) antagonist | 0.075 0.054 DBMET01768 | ||
| 0.199 | 0.046 | 0.199 | Protein-tyrosine kinase Lyn inhibitor | 0.125 0.081 DBMET01768 | ||
| 0.196 | 0.043 | 0.196 | Glycogen synthase kinase-3 alpha inhibitor | 0.184 0.047 DBMET01768 | ||
| 0.212 | 0.06 | 0.212 | CDC-like kinase 2 inhibitor | 0.147 0.095 DBMET01768 | ||
| 0.293 | 0.142 | 0.293 | MAP kinase kinase 6 inhibitor | 0.255 0.184 DBMET01768 | ||
| 0.19 | 0.04 | 0.19 | Cyclin-dependent kinase inhibitor | 0.119 0.074 DBMET01768 | ||
| 0.21 | 0.062 | 0.21 | CDC-like kinase 4 inhibitor | 0.135 0.114 DBMET01768 | ||
| 0.16 | 0.014 | 0.16 | I kappa B kinase inhibitor | 0.143 0.018 DBMET01768 | ||
| 0.176 | 0.031 | 0.176 | Nav1.6 sodium channel blocker | 0.133 0.076 DBMET01768 | ||
| 0.218 | 0.072 | 0.332 | Pyruvate kinase inhibitor | 0.332 0.039 DBMET01768 | DBMET01768 | |
| 0.186 | 0.042 | 0.186 | Vascular endothelial growth factor antagonist | 0.142 0.058 DBMET01768 | ||
| 0.162 | 0.019 | 0.209 | Carbonic anhydrase XIII inhibitor | 0.209 0.013 DBMET01768 | DBMET01768 | |
| 0.217 | 0.082 | 0.217 | Potassium channel blocker | |||
| 0.176 | 0.041 | 0.176 | Vascular endothelial growth factor 2 antagonist | 0.13 0.056 DBMET01768 | ||
| 0.142 | 0.011 | 0.142 | Phosphodiesterase III inhibitor | 0.123 0.014 DBMET01768 | ||
| 0.134 | 0.004 | 0.148 | Inosine monophosphate dehydrogenase inhibitor | 0.148 0.004 DBMET01768 | DBMET01768 | |
| 0.164 | 0.034 | 0.164 | Cyclin-dependent kinase 5 inhibitor | 0.141 0.045 DBMET01768 | ||
| 0.133 | 0.007 | 0.133 | Phosphodiesterase X inhibitor | 0.061 0.02 DBMET01768 | ||
| 0.133 | 0.007 | 0.133 | Phosphodiesterase 10A inhibitor | 0.061 0.02 DBMET01768 | ||
| 0.128 | 0.004 | 0.128 | Protein kinase (CK1) epsilon inhibitor | 0.05 0.013 DBMET01768 | ||
| 0.146 | 0.022 | 0.199 | Carbonic anhydrase VI inhibitor | 0.199 0.013 DBMET01768 | DBMET01768 | |
| 0.161 | 0.038 | 0.161 | Antibacterial (Helicobacter pylori) | 0.16 0.038 DBMET01768 | ||
| 0.128 | 0.008 | 0.128 | Transforming growth factor beta 3 antagonist | 0.1 0.024 DBMET01768 | ||
| 0.136 | 0.018 | 0.142 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.142 0.017 DBMET01768 | DBMET01768 | |
| 0.291 | 0.175 | 0.291 | 5 Hydroxytryptamine release inhibitor | 0.282 0.187 DBMET01768 | ||
| 0.142 | 0.026 | 0.142 | Nitric-oxide synthase inhibitor | 0.092 0.073 DBMET01768 | ||
| 0.128 | 0.013 | 0.128 | MAP kinase kinase 10 inhibitor | 0.07 0.039 DBMET01768 | ||
| 0.124 | 0.009 | 0.124 | Alpha 2 adrenoreceptor agonist | 0.101 0.014 DBMET01768 | ||
| 0.147 | 0.034 | 0.149 | DNA repair enzyme inhibitor | 0.149 0.033 DBMET01768 | DBMET01768 | |
| 0.139 | 0.027 | 0.139 | Protein kinase A inhibitor | 0.112 0.038 DBMET01768 | ||
| 0.117 | 0.005 | 0.117 | Glucosylceramidase inhibitor | 0.096 0.009 DBMET01768 | ||
| 0.167 | 0.057 | 0.173 | CDC-like kinase 1 inhibitor | 0.173 0.053 DBMET01768 | DBMET01768 | |
| 0.139 | 0.031 | 0.201 | Beta glucuronidase inhibitor | 0.201 0.013 DBMET01768 | DBMET01768 | |
| 0.135 | 0.028 | 0.135 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.093 0.053 DBMET01768 | ||
| 0.128 | 0.022 | 0.128 | Inducible nitric-oxide synthase inhibitor | 0.087 0.052 DBMET01768 | ||
| 0.108 | 0.004 | 0.108 | Fructose-1,6-bisphosphatase inhibitor | 0.105 0.004 DBMET01768 | ||
| 0.172 | 0.069 | 0.172 | Src kinase inhibitor | 0.166 0.073 DBMET01768 | ||
| 0.159 | 0.058 | 0.159 | Ribosomal protein S6 kinase inhibitor | 0.132 0.079 DBMET01768 | ||
| 0.115 | 0.016 | 0.115 | MAP3K7 inhibitor | 0.094 0.026 DBMET01768 | ||
| 0.159 | 0.061 | 0.174 | CF transmembrane conductance regulator agonist | 0.174 0.042 DBMET01768 | DBMET01768 | |
| 0.139 | 0.042 | 0.139 | MAP kinase 13 inhibitor | 0.096 0.088 DBMET01768 | ||
| 0.151 | 0.054 | 0.151 | Sodium channel (voltage-gated) blocker | |||
| 0.11 | 0.014 | 0.11 | Neuropeptide Y5 antagonist | |||
| 0.112 | 0.017 | 0.112 | Purinergic P2 antagonist | |||
| 0.19 | 0.097 | 0.19 | HERG channel blocker | |||
| 0.105 | 0.012 | 0.105 | Transcription factor AP-1 inhibitor | 0.083 0.019 DBMET01768 | ||
| 0.128 | 0.037 | 0.128 | CDK2/cyclin A inhibitor | 0.095 0.062 DBMET01768 | ||
| 0.151 | 0.061 | 0.151 | RET inhibitor | 0.146 0.063 DBMET01768 | ||
| 0.144 | 0.055 | 0.171 | MAP kinase kinase inhibitor | 0.171 0.041 DBMET01768 | DBMET01768 | |
| 0.117 | 0.031 | 0.117 | Neuropeptide Y antagonist | 0.078 0.062 DBMET01768 | ||
| 0.103 | 0.021 | 0.103 | I kappa B kinase 1 inhibitor | 0.07 0.048 DBMET01768 | ||
| 0.098 | 0.018 | 0.098 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.121 | 0.042 | 0.121 | Gastric antisecretory | 0.109 0.054 DBMET01768 | ||
| 0.088 | 0.012 | 0.088 | Glutamate (mGluR group III) agonist | 0.065 0.017 DBMET01768 | ||
| 0.111 | 0.036 | 0.111 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.102 | 0.027 | 0.102 | Syk tyrosine kinase inhibitor | 0.08 0.04 DBMET01768 | ||
| 0.09 | 0.016 | 0.09 | I kappa B kinase 2 inhibitor | 0.079 0.023 DBMET01768 | ||
| 0.118 | 0.045 | 0.118 | Fibroblast growth factor 1 antagonist | 0.088 0.067 DBMET01768 | ||
| 0.079 | 0.007 | 0.079 | Heparanase inhibitor | 0.076 0.008 DBMET01768 | ||
| 0.083 | 0.012 | 0.083 | H+/K+-transporting ATPase inhibitor | 0.068 0.019 DBMET01768 | ||
| 0.076 | 0.006 | 0.076 | Glutamate (mGluR4) agonist | 0.064 0.008 DBMET01768 | ||
| 0.138 | 0.068 | 0.138 | Aurora-C kinase inhibitor | 0.125 0.093 DBMET01768 | ||
| 0.089 | 0.019 | 0.09 | Carbonic anhydrase VB inhibitor | 0.09 0.019 DBMET01768 | DBMET01768 | |
| 0.105 | 0.038 | 0.105 | TIE antagonist | |||
| 0.089 | 0.022 | 0.089 | Protein kinase C iota inhibitor | 0.055 0.045 DBMET01768 | ||
| 0.103 | 0.037 | 0.103 | TIE-2 antagonist | |||
| 0.178 | 0.113 | 0.178 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.079 | 0.016 | 0.079 | MAP kinase kinase 9 inhibitor | 0.054 0.041 DBMET01768 | ||
| 0.123 | 0.059 | 0.123 | Glycogen synthase kinase-3 inhibitor | |||
| 0.097 | 0.034 | 0.097 | Phosphodiesterase 3A inhibitor | 0.092 0.04 DBMET01768 | ||
| 0.093 | 0.031 | 0.093 | Alpha adrenoreceptor agonist | 0.089 0.032 DBMET01768 | ||
| 0.207 | 0.146 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.083 | 0.022 | 0.083 | Prostaglandin antagonist | 0.052 0.038 DBMET01768 | ||
| 0.116 | 0.056 | 0.119 | Protein kinase C gamma inhibitor | 0.119 0.053 DBMET01768 | DBMET01768 | |
| 0.092 | 0.033 | 0.092 | Polo-like kinase-2 inhibitor | 0.064 0.06 DBMET01768 | ||
| 0.089 | 0.03 | 0.096 | Carbonic anhydrase VA inhibitor | 0.096 0.027 DBMET01768 | DBMET01768 | |
| 0.117 | 0.059 | 0.117 | Polo-like kinase-4 inhibitor | 0.092 0.086 DBMET01768 | ||
| 0.152 | 0.095 | 0.152 | LIM domain kinase 1 inhibitor | |||
| 0.16 | 0.103 | 0.16 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.234 | 0.178 | 0.325 | 15-Lipoxygenase inhibitor | 0.325 0.115 DBMET01768 | DBMET01768 | |
| 0.13 | 0.074 | 0.13 | Sodium channel blocker | |||
| 0.243 | 0.189 | 0.243 | Analgesic | |||
| 0.075 | 0.022 | 0.088 | Fatty acid synthase inhibitor | 0.088 0.015 DBMET01768 | DBMET01768 | |
| 0.165 | 0.112 | 0.169 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.169 0.108 DBMET01768 | DBMET01768 | |
| 0.083 | 0.03 | 0.083 | Phosphodiesterase VIII inhibitor | |||
| 0.078 | 0.026 | 0.083 | Purinergic P2X1 antagonist | 0.083 0.024 DBMET01768 | DBMET01768 | |
| 0.078 | 0.028 | 0.078 | 5 Hydroxytryptamine 3 agonist | 0.058 0.052 DBMET01768 | ||
| 0.204 | 0.154 | 0.204 | Prostaglandin dehydrogenase inhibitor | 0.203 0.154 DBMET01768 | ||
| 0.062 | 0.013 | 0.062 | Guanylate cyclase stimulant | 0.043 0.03 DBMET01768 | ||
| 0.089 | 0.04 | 0.089 | Fibroblast growth factor 3 antagonist | |||
| 0.067 | 0.019 | 0.067 | Purinergic P2X antagonist | |||
| 0.058 | 0.01 | 0.058 | Purinergic P2X7 antagonist | |||
| 0.05 | 0.005 | 0.05 | Guanylate cyclase 1 stimulant | 0.023 0.01 DBMET01768 | ||
| 0.064 | 0.02 | 0.064 | Glutamate (mGluR5) antagonist | |||
| 0.083 | 0.039 | 0.083 | Adenosine A3 receptor antagonist | 0.069 0.06 DBMET01768 | ||
| 0.109 | 0.065 | 0.113 | DNA intercalator | 0.113 0.062 DBMET01768 | DBMET01768 | |
| 0.113 | 0.073 | 0.113 | TRKA antagonist | |||
| 0.077 | 0.037 | 0.086 | Carbonic anhydrase V inhibitor | 0.086 0.032 DBMET01768 | DBMET01768 | |
| 0.109 | 0.07 | 0.109 | Nav1.5 sodium channel blocker | |||
| 0.107 | 0.068 | 0.107 | 5 Hydroxytryptamine 3A agonist | |||
| 0.041 | 0.005 | 0.041 | Alpha 2d adrenoreceptor agonist | 0.026 0.011 DBMET01768 | ||
| 0.075 | 0.039 | 0.075 | CDC7 inhibitor | |||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | |||
| 0.068 | 0.034 | 0.068 | Adenosine A1 receptor antagonist | 0.058 0.041 DBMET01768 | ||
| 0.045 | 0.013 | 0.045 | Potassium channel small-conductance Ca-activated activator | |||
| 0.095 | 0.063 | 0.095 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.036 | 0.004 | 0.036 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 DBMET01768 | ||
| 0.118 | 0.087 | 0.118 | Lck kinase inhibitor | |||
| 0.043 | 0.012 | 0.043 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.032 | 0.001 | 0.032 | CXC chemokine 3 receptor agonist | 0.024 0.001 DBMET01768 | ||
| 0.057 | 0.026 | 0.057 | AMPA receptor antagonist | 0.047 0.034 DBMET01768 | ||
| 0.088 | 0.057 | 0.088 | Acetylcholine agonist | |||
| 0.169 | 0.139 | 0.169 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.151 | 0.121 | 0.151 | Death-associated protein kinase 3 inhibitor | |||
| 0.088 | 0.059 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.06 DBMET01768 | ||
| 0.192 | 0.162 | 0.249 | Hypoxia-inducible factor 1 alpha inhibitor | 0.249 0.102 DBMET01768 | DBMET01768 | |
| 0.042 | 0.014 | 0.042 | Purinergic P2Y2 antagonist | 0.036 0.02 DBMET01768 | ||
| 0.033 | 0.006 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.031 0.007 DBMET01768 | ||
| 0.045 | 0.019 | 0.045 | TRPM8 blocker | |||
| 0.101 | 0.075 | 0.101 | GABA receptor agonist | |||
| 0.05 | 0.025 | 0.062 | Phosphodiesterase 3B inhibitor | 0.062 0.019 DBMET01768 | DBMET01768 | |
| 0.086 | 0.061 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | 0.087 0.058 DBMET01768 | DBMET01768 | |
| 0.074 | 0.05 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.07 | 0.046 | 0.075 | Check point kinase 1 inhibitor | 0.075 0.041 DBMET01768 | DBMET01768 | |
| 0.089 | 0.066 | 0.108 | Protein kinase C zeta inhibitor | 0.108 0.042 DBMET01768 | DBMET01768 | |
| 0.033 | 0.011 | 0.033 | HCV NS5A inhibitor | |||
| 0.034 | 0.014 | 0.034 | CDK4/cyclin D3 inhibitor | |||
| 0.06 | 0.041 | 0.06 | Potassium channel (Ca-activated) blocker | |||
| 0.169 | 0.15 | 0.169 | Calpain inhibitor | |||
| 0.11 | 0.092 | 0.11 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.046 | 0.028 | 0.046 | Stearoyl-CoA desaturase inhibitor | |||
| 0.066 | 0.049 | 0.066 | Nav1.7 sodium channel blocker | |||
| 0.021 | 0.005 | 0.021 | CDK2/cyclin A3 inhibitor | |||
| 0.07 | 0.054 | 0.07 | Orexin receptor 1 antagonist | |||
| 0.054 | 0.039 | 0.054 | Acetylcholine muscarinic agonist | |||
| 0.048 | 0.034 | 0.051 | Dopamine beta hydroxylase inhibitor | 0.051 0.028 DBMET01768 | DBMET01768 | |
| 0.044 | 0.032 | 0.044 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.021 | 0.009 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.058 | 0.046 | 0.058 | Adenosine A2a receptor antagonist | |||
| 0.026 | 0.015 | 0.026 | Complement factor 1s inhibitor | |||
| 0.051 | 0.04 | 0.051 | GABA A receptor antagonist | |||
| 0.041 | 0.031 | 0.041 | Acetylcholine M1 receptor agonist | |||
| 0.085 | 0.075 | 0.085 | Platelet activating factor beta antagonist | 0.085 0.075 DBMET01768 | ||
| 0.109 | 0.099 | 0.109 | Toll-Like receptor 9 antagonist | |||
| 0.086 | 0.077 | 0.086 | MAP kinase kinase 1 inhibitor | 0.084 0.08 DBMET01768 | ||
| 0.06 | 0.053 | 0.06 | Aryl hydrocarbon receptor antagonist | |||
| 0.064 | 0.056 | 0.064 | ZAP-70 protein tyrosine kinase inhibitor | 0.063 0.058 DBMET01768 | ||
| 0.073 | 0.065 | 0.099 | Platelet growth factor antagonist | 0.099 0.041 DBMET01768 | DBMET01768 | |
| 0.069 | 0.061 | 0.069 | ErbB-2 antagonist | 0.067 0.065 DBMET01768 | ||
| 0.057 | 0.05 | 0.057 | Cyclin A2 inhibitor | |||
| 0.051 | 0.045 | 0.051 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.057 | 0.051 | 0.057 | Adenosine A2 receptor antagonist | |||
| 0.193 | 0.187 | 0.193 | Antithrombotic | |||
| 0.061 | 0.055 | 0.061 | Orexin receptor antagonist | |||
| 0.091 | 0.085 | 0.11 | EphA2 antagonist | 0.11 0.065 DBMET01768 | DBMET01768 | |
| 0.035 | 0.03 | 0.035 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.05 | 0.044 | 0.05 | GABA receptor antagonist | |||
| 0.037 | 0.032 | 0.037 | AMPA 4 receptor antagonist | |||
| 0.017 | 0.012 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.039 | 0.034 | 0.039 | Guanylate cyclase inhibitor | |||
| 0.028 | 0.025 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.084 | 0.083 | 0.084 | MAP kinase kinase kinase inhibitor | |||
| 0.018 | 0.017 | 0.018 | Hexokinase stimulant | |||
| 0.121 | 0.123 | 0.124 | GABA C receptor rho-2 antagonist | 0.124 0.117 DBMET01768 | DBMET01768 | |
| 0.118 | 0.121 | 0.146 | Hexokinase inhibitor | 0.146 0.084 DBMET01768 | DBMET01768 | |
| 0.071 | 0.076 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.024 DBMET01768 | DBMET01768 | |
| 0.064 | 0.068 | 0.109 | Topoisomerase II alpha inhibitor | 0.109 0.034 DBMET01768 | DBMET01768 | |
| 0.088 | 0.097 | 0.102 | Nav1.4 sodium channel blocker | 0.102 0.073 DBMET01768 | DBMET01768 | |
| 0.164 | 0.178 | 0.183 | DNA synthesis inhibitor | 0.183 0.149 DBMET01768 | DBMET01768 | |
| 0.088 | 0.105 | 0.119 | DOPA decarboxylase inhibitor | 0.119 0.046 DBMET01768 | DBMET01768 | |
| 0.243 | 0.262 | 0.32 | Caspase 9 stimulant | 0.32 0.173 DBMET01768 | DBMET01768 | |
| 0.05 | 0.075 | 0.07 | Phenylalanine 4-hydroxylase inhibitor | 0.07 0.046 DBMET01768 | DBMET01768 | |
| 0.061 | 0.092 | 0.106 | Adrenaline agonist | 0.106 0.033 DBMET01768 | DBMET01768 | |
| 0.169 | 0.203 | 0.2 | Tyrosine 3 hydroxylase inhibitor | 0.2 0.135 DBMET01768 | DBMET01768 | |
| 0.124 | 0.168 | 0.202 | Aldehyde oxidase inhibitor | 0.202 0.104 DBMET01768 | DBMET01768 | |
| 0.08 | 0.132 | 0.101 | Epidermal growth factor receptor kinase inhibitor | 0.101 0.096 DBMET01768 | DBMET01768 | |
| 0.14 | 0.216 | 0.213 | Lipoxygenase inhibitor | 0.213 0.128 DBMET01768 | DBMET01768 | |
| 0.083 | 0.161 | 0.14 | Peroxidase inhibitor | 0.14 0.084 DBMET01768 | DBMET01768 | |
| 0.198 | 0.279 | 0.255 | Cyclophilin D inhibitor | 0.255 0.207 DBMET01768 | DBMET01768 | |
| 0.109 | 0.199 | 0.135 | MAP kinase kinase 4 inhibitor | 0.135 0.097 DBMET01768 | DBMET01768 | |
| 0.093 | 0.185 | 0.135 | NOS3 expression enhancer | 0.135 0.09 DBMET01768 | DBMET01768 | |
| 0.058 | 0.174 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.081 DBMET01768 | DBMET01768 | |
| 0.09 | 0.211 | 0.131 | Dual specificity phosphatase inhibitor | 0.131 0.119 DBMET01768 | DBMET01768 | |
| 0.056 | 0.179 | 0.126 | Tubulin antagonist | 0.126 0.074 DBMET01768 | DBMET01768 | |
| 0.036 | 0.186 | 0.074 | Macrophage migration inhibitory factor inhibitor | 0.074 0.059 DBMET01768 | DBMET01768 | |
| 0.015 | 0.182 | 0.052 | Alpha tubulin antagonist | 0.052 0.038 DBMET01768 | DBMET01768 | |
| 0.042 | 0.209 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 DBMET01768 | DBMET01768 | |
| 0.034 | 0.208 | 0.11 | M18 aspartyl aminopeptidase inhibitor | 0.11 0.08 DBMET01768 | DBMET01768 | |
| 0.119 | 0.31 | 0.176 | ErbB-1 antagonist | 0.176 0.122 DBMET01768 | DBMET01768 | |
| 0.133 | 0.454 | 0.367 | Calcium channel L-type activator | 0.367 0.105 DBMET01768 | DBMET01768 | |
| 0.004 | 0.964 | 0.103 | Estrogen antagonist | 0.103 0.091 DBMET01768 | DBMET01768 | |
| 0.004 | 0.966 | 0.093 | Estrogen receptor beta antagonist | 0.093 0.078 DBMET01768 | DBMET01768 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |